First OTC cannabis by early 2023?

Wellnex Life hoping for SAS OK by year’s end with S3 approval to follow in next quarter - and a market potentially worth "billions" ASX-listed health and wellness outfit Wellnex is aiming to be the first company to produce and market an over-the-counter cannabis preparation, ramping up its efforts for S3 approval for a market

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous World news wrapup: 6 October 2022
Next Fentanyl use skyrockets